US regulators have approved an additional generic version of the abortion pill mifepristone, a normally routine move that nevertheless angered anti-abortion activists.

A number of conservative figures and anti-abortion groups decried the regulatory step, with the institution Students for Life Action calling it “a stain on the Trump presidency.”

The drugmaker Evita said on its website the US Food and Drug Administration had this week approved the company’s generic tablet, which is currently approved to end pregnancies up to 70 days of gestation.

The medication is used in the majority of abortions in the United States, and also routinely used for managing early miscarriage.

The FDA originally approved mifepristone in 2000, and another generic already exists.

Approvals of additional gene

See Full Page